Cortot A, Le X, Smit E, Viteri S, et al. Safety of MET Tyrosine Kinase Inhibitors in Patients With MET Exon 14 Skipping Non-small Cell Lung Cancer: A Clinical Review. Clin Lung Cancer 2022 Feb 4. pii: S1525-7304(22)00013.
PMID: 35272955